Document Detail


Down's syndrome: current screening techniques.
MedLine Citation:
PMID:  2480649     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Antenatal screening for Down's syndrome traditionally relied upon performing amniocentesis for karyotype on pregnant women aged 35 years and older. This method detects approximately 20% of all Down's syndrome pregnancies, with a false-positive rate of 4.3%. By incorporating maternal serum alpha-fetoprotein values as an additional screening parameter to maternal age, 28% of all Down's syndrome pregnancies may be diagnosed, with a 35% reduction in false-positive results. Other screening parameters such as maternal serum unconjugated estriol and human chorionic gonadotropin may eventually make it possible to detect more than 65% of pregnancies with chromosomally abnormal fetuses, without compromise in false-positive rates.
Authors:
R S White
Related Documents :
9834719 - Routine prenatal screening for hiv in a low-prevalence setting.
25021059 - Pmm.59 maternal hypothyroxinaemia in pregnancy is associated with altered maternal meta...
20356939 - Distribution of nuchal translucency in antenatal screening for down's syndrome.
10428329 - First trimester malformation screening.
10419619 - Maternal serum prostate-specific antigen and down syndrome in the first and second trim...
17636459 - Racial and ethnic disparities in prenatal syphilis screening among women with medicaid-...
16979229 - Logistic regression analysis of pregnancy rate following transfer of bos indicus embryo...
15388199 - Acute asthma in pregnancy.
10081859 - Repeat vasectomy reversal after initial failure: overall results and predictors for suc...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Southern medical journal     Volume:  82     ISSN:  0038-4348     ISO Abbreviation:  South. Med. J.     Publication Date:  1989 Dec 
Date Detail:
Created Date:  1990-01-23     Completed Date:  1990-01-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0404522     Medline TA:  South Med J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1483-6     Citation Subset:  AIM; IM    
Affiliation:
Department of Obstetrics and Gynecology, George Washington University Medical Center, Washington, DC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amniocentesis
Down Syndrome / blood,  diagnosis*
False Positive Reactions
Female
Fetal Diseases / blood,  diagnosis*
Humans
Maternal Age*
Pregnancy
Prenatal Diagnosis / methods*,  standards
Probability
Reagent Kits, Diagnostic / standards*
Risk Factors
alpha-Fetoproteins / analysis*
Chemical
Reg. No./Substance:
0/Reagent Kits, Diagnostic; 0/alpha-Fetoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical approaches to families in early intervention.
Next Document:  X-linked agammaglobulinaemia.